ConductScience.org, home

Comparison · NCT03846544-c01b3a39

Double Pick up Group vs Control Group: Clinical Pregnancy Rates

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Double Pick up Group vs Control Group: Clinical Pregnancy Rates. Trial comparisons, record NCT03846544-c01b3a39. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03846544-c01b3a39

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.5650.3680.744wilson
Risk in group 20.3040.1560.509wilson
Risk difference, group 1 minus group 20.261-0.0230.493newcombe hybrid score
Risk ratio, group 1 over group 21.860.9093.79log
Odds ratio, group 1 over group 22.970.8849.98log
Number needed to treat, for one more participant with the outcome on Double Pick up Group than on Control Group3.83from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Double Pick up Group
CFA-double pick up: In the study group, 225 IU of rFSH will continue after the first oocyte retrieval (OR). Antagonist administration will be initiated when at least one follicle measuring ≥14 mm will be present in the ultrasound. If one or more follicles ≥17 mm are observed, patients will undergo a second triggering with hCG 5000 IU and a second OR will be performed. In case of patients with no follicular development following 10 additional days of rFSH post-OR
1323OG001
Group 2Control Groupconventional stimulation group723OG000

Outcome

Type
SECONDARY
Title
Clinical Pregnancy Rates
Description
clinical pregnancy rate
Time frame
4 months
Population

Source ClinicalTrials.gov

Trial

Title
Double Pick up in Poor Prognosis Women
NCT number
NCT03846544
Phases
PHASE4
Conditions
Fertility Disorders
Interventions
Corifollitoropin alfa (CFA)-double pick up
Lead sponsor
CRG UZ Brussel
Results first posted
2024-04-15

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03846544-c01b3a39